Evidence for divergence of DNA copy number changes in serous, mucinous and endometrioid ovarian carcinomas

British Journal of Cancer

Volumn 75, Issue 12, 1997, Pages 1782-1787

  Tapper, J ^a   Butzow R ^a   Wahlstrom T ^a   Seppala M ^a   Knuutila, S ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Comparative genomic hybridization; DNA copy number change; Histology; Ovarian carcinoma

Indexed keywords

DNA;

ARTICLE; CHROMOSOME 13Q; CHROMOSOME 17Q; CHROMOSOME 1Q; CHROMOSOME 2P; CHROMOSOME 7Q; CHROMOSOME 8P; CHROMOSOME 8Q; CHROMOSOME 9P; CLINICAL ARTICLE; ENDOMETRIOID CARCINOMA; FEMALE; HUMAN; OVARY CARCINOMA; PRIORITY JOURNAL;

EID: 0030969847     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.304     Document Type: Article

References (31)

1. Arnold N, Hägele L, Walz L, Schempp W, Pfisterer J, Bauknecht T and Kiechle M (1996) Overrepresentation of 3q and 8q material and loss of 18q material are recurrent findings in advanced human ovarian cancer. Genes Chromosom Cancer 16: 46-54
2. Berchuck A, Kamel A, Whitaker R, Kerns B, Olt G, Kinney R, Soper JT, Dodge R, Clarke-Pearson DL, Marks P, McKenzie S, Yin S and Bast Jr RC (1990) Overexpression of HER-/neu is associated with poor survival in advanced epithelial ovarian cancer. Cancer Res 50: 4087-4091
3. Bosari S, Viale G, Radaelli U, Bossi P, Bonoldi E and Coggi G (1993) p53 accumulation in ovarian carcinomas and its prognostic implications. Hum Pathol 24: 1175-1179
4. Chenevix-Trench G, Kerr J, Friedlander M, Hurst T, Sanderson B, Coglan M, Ward B, Leary J and Khoo S-K (1994) Homozygous deletions on the short arm of chromosome 9 in ovarian adenocarcinoma cell lines and loss of heterozygosity in sporadic tumors. Am J Hum Genet 55: 143-149
5. Cliby W, Ritland S, Hartmann L, Dodson M, Halling KC, Keeney G, Podratz KC and Jenkins RB (1993) Human epithelial ovarian cancer allelotype. Cancer Res 53: 2393-2398
6. Corey SJ and Shapiro DN (1994) Localization of the human gene for Scr-related protein tyrosine kinase LYN to chromosome 8q11-12: a lymphoid signalling cluster? Leukemia 8: 1914-1917
7. Dodson MK, Cliby WA, Xu H-J, Delacey KA, Hu S-X, Keeney GL, Li J, Podratz KC, Jenkins RB and Benedict WF (1994) Evidence of functional RB protein in epithelial ovarian carcinomas despite loss of heterozygosity at the RB locus. Cancer Res 54: 610-613
8. Enomoto T, Inoue M, Perantoni AO, Terakawa N, Tanizawa O and Rice JM (1990) K-ras activation in neoplasms of the human female reproductive tract. Cancer Res 50: 6139-6145
9. Hruza C, Dobianer K, Beck A, Czerwenka K, Hanak H, Klein M, Leodolter S, Medl M, Müllauer-Ertl S, Preiser J, Rosen A, Salzer H, Sevelda P and Spona J (1993) HER-2 and INT-2 amplification estimated by quantitative PCR in paraffin embedded ovarian cancer tissue samples. Eur J Cancer 29A: 1593-1597
10. Ichikawa Y, Nishida M, Suzuki H, Yoshida S, Tsunoda H, Kubo T, Uchida K and Miwa M (1994) Mutation of K-ras protooncogene is associated with histological subtypes in human mucinous ovarian tumors. Cancer Res 54: 33-35
11. Iwabuchi H, Sakamoto M, Sakunaga H, Ma Y-Y, Carcangiu ML, Pinkel D, Yang-Feng TL and Gray JW (1995) Genetic analysis of benign, low-grade, and high-grade ovarian tumors. Cancer Res 55: 6172-6180
12. Kallioniemi A, Kallioniemi O-P, Sudar D, Rutovitz D, Gray JW, Waldman F and Pinkel D (1992) Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258: 818-821
13. Kallioniemi O-P, Kallioniemi A, Piper J, Isola J, Waldman FM, Gray JW and Pinkel D (1994) Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosom Cancer 10: 231-243
14. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day III RS, Johnson BE and Skolnick MH (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264: 436-440
15. Kiechle-Schwarz M, Bauknecht T, Wienker T, Walz L and Pfleiderer A (1993) Loss of constitutional heterozygosity on chromosome 11p in human ovarian cancer. Cancer 72: 2423-2432
16. Kim TM, Benedict WF, Xu H-J, Hu S-X, Gosewehr J, Velicescu M, Yin E, Zheng J, D'Ablaing G and Dubeau L (1994) Loss of heterozygosity on chromosome 13 is common only in the biologically more aggressive subtypes of ovarian epithelial tumors and is associated with normal retinoblastoma gene expression. Cancer Res 54: 605-609
17. Klemi P-J, Pylkkänen L, Kiilholma P, Kurvinen K and Joensuu H (1995) p53 protein detected by immunohistochemistry as a prognostic factor in patients with epithelial ovarian carcinoma. Cancer 76: 1201-1208
18. Kohler MF, Kerns B-JM, Humphrey PA, Marks JR, Bast Jr RC and Berchuck A (1993) Mutation and overexpression of p53 in early-stage epithelial ovarian cancer. Obstet Gynecol 81: 643-650
19. Makar AP, Baekelandt M, Tropé CG and Kristensen GB (1995) The prognostic significance of residual disease, FIGO substage, tumor histology, and grade in patients with FIGO stage III ovarian cancer. Gynecol Oncol 56: 175-180
20. Marks JR, Davidoff AM, Kerns BJ, Humphrey PA, Pence JC, Dodge RK, Clarke-Pearson DL, Iglehart JD, Bast Jr RC and Berchuck A (1991) Overexpression and mutation of p53 in epithelial ovarian cancer. Cancer Res 51: 2979-2984
21. Medl M, Sevelda P, Czerwenka K, Dobianer K, Hanak H, Hruza C, Klein M, Leodolter S, Müllauer-Ertl S, Rosen A, Salzer H, Vavra N and Spona J (1995) DNA amplification of HER-2/neu and INT-2 oncogenes in epithelial ovarian cancer. Gynecol Oncol 59: 321-326
22. Mok SC-H, Bell DA, Knapp RC, Fishbaugh PM, Welch WR, Muto MG, Berkowitz RS and Tsao S-W (1993) Mutation of K-ras protooncogene in human epithelial tumors of borderline malignancy. Cancer Res 53: 1489-1492
23. Pejovic T, Heim S, Mandahl N, Baldetorp B, Elmfors B, Flodérus U-M, Furgyik S, Helm G, Himmelmann A, Willén H and Mitelman F (1992) Chromosome aberrations in 35 primary ovarian carcinomas. Genes Chromosom Cancer 4: 58-68
24. Pietras RJ, Fendly BM, Chazin VR, Pegram MD, Howell SB and Slamon DJ (1994) Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cells. Oncogene 9: 1829-1838
25. Saito S, Saito H, Koi S, Sagae S, Kudo R, Saito J, Noda K and Nakamura Y (1992) Fine-scale deletion mapping of the distal long arm of chromosome 6 in 70 human ovarian cancers. Cancer Res 52: 5815-5817
26. Sasano H, Garett CT, Wilkinson DS, Silverberg S, Comerford J and Hyde J (1990) Protooncogene amplification and tumor ploidy in human ovarian neoplasms. Hum Pathol 21: 382-391
27. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A and Press MF (1989) Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244: 707-712
28. Takahashi H, Behbakht K, McGovern PE, Chiu H-C, Couch FJ, Weber BL, Friedman LS, King M-C, Furusato M, Livolsi VA, Menzin AW, Liu PC, Benjamin I, Morgan MA, King SA, Rebane BA, Cardonick A, Mikuta JJ, Rubin SC and Boyd J (1995) Mutation analysis of the BRCA1 gene in ovarian cancers. Cancer Res 55: 2998-3002
29. Tsuda H, Hirohashi S, Shimosato Y, Hirota T, Tsugane S, Yamamoto H, Miyajima N, Toyoshima K, Yamamoto T, Yokota J, Yoshida T, Sakamoto H, Terada M and Sugimura T (1989) Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-1/int-2 and c-erbB-2/ear-1. Cancer Res 49: 3104-3108
30. Whang-Peng J, Knutsen T, Douglass EC, Chu E, Ozols RF, Hogan WM and Young RC (1984) Cytogenetic studies in ovarian cancer. Cancer Genet Cytogenet 11: 91-106
31. Zheng J, Robinson WR, Ehlen T, Yu MC and Dubeau L (1991) Distinction of low grade from high grade human ovarian carcinomas on the basis of losses of heterozygosity on chromosomes 3, 6 and 11 and HER-2/neu gene amplification. Cancer Res 51: 4045-4051